Astoriom is excited to announce the appointment of Lori A. Ball as Chief Executive Officer, marking a significant step in the company’s determination to continue enhancing the value they deliver to their customers. Ms. Ball's extensive background in the life sciences industry, particularly in global sample management and biospecimen storage, positions her uniquely to lead Astoriom in expanding and refining their service offerings.
Lori's leadership will focus on enhancing the quality and reliability of Astoriom’s sample stability and biospecimen storage solutions, ensuring that their customers receive unparalleled service tailored to their specific needs. Her strategic vision includes expanding Astoriom's service portfolio and geographical presence, making it easier for clients to access cutting-edge storage solutions across multiple regions. This commitment to innovation and customer satisfaction underlines Astoriom’s dedication to supporting the evolving needs of their clients in the pharmaceutical, biologic, and medical device sectors.
Ms. Ball's leadership will bring new opportunities for collaboration and innovation, further solidifying Astoriom as a trusted partner in the industry. Her experience and customer-centric approach will be instrumental in helping Astoriom's clients achieve their research and development goals more efficiently and effectively.
For more information about how Astoriom can support your business, visit our website at Astoriom.